Q2 2018 13F Holders as of 6/30/2018
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
71.9M
-
Number of holders
-
27
-
Total 13F shares, excl. options
-
6.39M
-
Shares change
-
-437K
-
Total reported value, excl. options
-
$47.7M
-
Value change
-
-$3.33M
-
Put/Call ratio
-
0.84
-
Number of buys
-
5
-
Number of sells
-
-16
-
Price
-
$7.46
Significant Holders of SINOVAC BIOTECH LTD. - Common Shares (SVA) as of Q2 2018
33 filings reported holding SVA - SINOVAC BIOTECH LTD. - Common Shares as of Q2 2018.
SINOVAC BIOTECH LTD. - Common Shares (SVA) has 27 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 6.39M shares
of 71.9M outstanding shares and own 8.89% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (2.84M shares), RENAISSANCE TECHNOLOGIES LLC (2.53M shares), Neumann Advisory Hong Kong Ltd (403K shares), STATE STREET CORP (134K shares), DEUTSCHE BANK AG\ (73.3K shares), CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM (70.1K shares), Yorktown Management & Research Co Inc (64.6K shares), Eqis Capital Management, Inc. (41.8K shares), Spark Investment Management LLC (39.6K shares), and SUSQUEHANNA INTERNATIONAL GROUP, LLP (37K shares).
This table shows the top 27 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.